Group One Trading’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Group One Trading’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-300	Closed	-$3K	–	5606
2017 Q3	$3K	Buy	+300	New	+$3.31K	﹤0.01%	4621
2015 Q4	–	Sell	-100	Closed	-$837	–	5405
2015 Q3	$1K	Buy	+100	New	+$856	﹤0.01%	4795
2015 Q2	–	Sell	-1,283	Closed	-$11.7K	–	5425
2015 Q1	$11K	Buy	+1,283	New	+$10.2K	﹤0.01%	4126
2014 Q2	–	Sell	-3,951	Closed	-$19.2K	–	5714
2014 Q1	$18K	Buy	+3,951	New	+$19.1K	﹤0.01%	4314
2013 Q3	–	Sell	-901	Closed	-$5.02K	–	5855
2013 Q2	$4K	Buy	+901	New	+$4.29K	﹤0.01%	4783

Group One Trading's SCLN Position: Q4 2017 in Review

Group One Trading sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 300 shares — an estimated $3K sold.

Group One Trading first reported a position in SCLN in Q2 2013 and held it in 5 quarters. The position peaked at $18K in Q1 2014. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Group One Trading reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Group One Trading sold 300 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $3K.
Group One Trading first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
Group One Trading's Sciclone Pharmaceuticals Inc position peaked at $18K in Q1 2014.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Group One Trading's 13F filing for Q4 2017, filed 9 Feb 2018.